Chief Financial Officer Michael Burkes Brophy reduced his stake in Natera Inc. (NASDAQ: NTRA) by selling 785 shares on March 10, 2026, at a per-share price of $204.1327, yielding proceeds of approximately $160,244.
The disposition occurred after a one-day transaction on March 9, 2026, when Brophy was issued 1,968 shares of common stock tied to Restricted Stock Units that were fully vested at issuance. Following these two transactions, Brophy directly holds 63,354 shares of Natera.
Market context around the sale shows the stock has produced a 36% return over the past 12 months. Despite that gain, shares are trading beneath Brophy’s sale price; the current quote is $196.61.
Separately, Natera reported its fourth-quarter 2025 financial results that surpassed revenue expectations. The company posted revenue of $666 million versus consensus estimates of $590.72 million, representing notable year-over-year growth for the period.
Analysts have reacted to the quarter with differing valuations and stances. Canaccord Genuity reiterated a Buy rating on the stock and maintained a $285 price target, citing robust test volume growth across Natera’s business segments. Morgan Stanley, while preserving an Overweight rating, trimmed its price target to $250 following adjustments to its model and noted the change reflects a discounted cash flow analysis underpinning its valuation.
The insider sale, the RSU issuance and the recent earnings beat together present a mixed picture: management pocketed proceeds from a sale at a price above the current market level, while the company delivered stronger-than-expected top-line performance that prompted divergent price targets among equity research firms.
Where relevant details were disclosed by the company and reflected in regulatory filings, Brophy’s transactions were executed on the dates reported and leave him with the direct share balance stated above.
Summary of facts:
- March 10, 2026 - Brophy sold 785 shares at $204.1327 per share, totaling about $160,244.
- March 9, 2026 - Brophy was issued 1,968 fully vested RSU shares.
- Post-transactions direct ownership: 63,354 shares.
- Q4 2025 revenue: $666 million versus expected $590.72 million.
- Current share price: $196.61; 12-month return: +36%.
- Canaccord Genuity: Buy rating, $285 price target; Morgan Stanley: Overweight rating, $250 price target (DCF-based).